HEADER HYDROLASE INHIBITOR 21-FEB-12 4DTE TITLE CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- TITLE 2 1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN COMPND 3 ACTIVATOR INHIBITOR TYPE 1), MEMBER 1; COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DANIO RERIO; SOURCE 3 ORGANISM_COMMON: LEOPARD DANIO,ZEBRA DANIO,ZEBRA FISH; SOURCE 4 ORGANISM_TAXID: 7955; SOURCE 5 GENE: SERPINE1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HUMAN EMBRYONIC KIDNEY CELLS (HEK-293); SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: KIDNEY KEYWDS ACTIVE SERPIN, HYDROLASE INHIBITOR, ZEBARFISH UPA EXPDTA X-RAY DIFFRACTION AUTHOR J.S.JOHANSEN REVDAT 8 13-SEP-23 4DTE 1 HETSYN REVDAT 7 29-JUL-20 4DTE 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE REVDAT 6 15-NOV-17 4DTE 1 REMARK REVDAT 5 21-AUG-13 4DTE 1 JRNL TITLE REVDAT 4 14-AUG-13 4DTE 1 JRNL REVDAT 3 07-AUG-13 4DTE 1 JRNL REVDAT 2 10-APR-13 4DTE 1 HETATM REVDAT 1 27-MAR-13 4DTE 0 JRNL AUTH R.BAGER,J.S.JOHANSEN,J.K.JENSEN,A.STENSBALLE,A.JENDROSZEK, JRNL AUTH 2 L.BUXBOM,H.P.SORENSEN,P.A.ANDREASEN JRNL TITL PROTEIN CONFORMATIONAL CHANGE DELAYED BY STERIC HINDRANCE JRNL TITL 2 FROM AN N-LINKED GLYCAN. JRNL REF J.MOL.BIOL. V. 425 2867 2013 JRNL REFN ISSN 0022-2836 JRNL PMID 23702291 JRNL DOI 10.1016/J.JMB.2013.05.007 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 60303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.320 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.7590 - 4.7223 0.98 4239 146 0.1540 0.1677 REMARK 3 2 4.7223 - 3.7488 0.99 4218 144 0.1348 0.1856 REMARK 3 3 3.7488 - 3.2751 0.99 4171 144 0.1524 0.1989 REMARK 3 4 3.2751 - 2.9757 0.99 4185 143 0.1706 0.2106 REMARK 3 5 2.9757 - 2.7625 0.99 4164 143 0.1746 0.2275 REMARK 3 6 2.7625 - 2.5996 0.99 4163 143 0.1816 0.2281 REMARK 3 7 2.5996 - 2.4694 0.99 4163 142 0.1863 0.2191 REMARK 3 8 2.4694 - 2.3620 0.99 4171 143 0.1956 0.2391 REMARK 3 9 2.3620 - 2.2710 0.99 4150 143 0.2014 0.2908 REMARK 3 10 2.2710 - 2.1927 0.99 4151 142 0.2128 0.3056 REMARK 3 11 2.1927 - 2.1241 0.99 4172 143 0.2303 0.2902 REMARK 3 12 2.1241 - 2.0634 1.00 4187 143 0.2400 0.3043 REMARK 3 13 2.0634 - 2.0091 1.00 4155 143 0.2564 0.3184 REMARK 3 14 2.0091 - 1.9601 0.96 4014 138 0.2632 0.3217 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.75270 REMARK 3 B22 (A**2) : -1.92120 REMARK 3 B33 (A**2) : 6.67390 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.21080 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.019 5963 REMARK 3 ANGLE : 1.757 8049 REMARK 3 CHIRALITY : 0.131 909 REMARK 3 PLANARITY : 0.009 1038 REMARK 3 DIHEDRAL : 16.087 2253 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DTE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000070758. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 II REMARK 200 DATA SCALING SOFTWARE : XIA2 II REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60335 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 59.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 11.980 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3Q02 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% (W/V) PEG3350, 0.2 M NACL, 0.1 M REMARK 280 BIS-TRIS, PH 6.1, VAPOR DIFFUSION, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.88500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 329 REMARK 465 ALA B 330 REMARK 465 THR B 331 REMARK 465 ALA B 332 REMARK 465 ALA B 333 REMARK 465 VAL B 334 REMARK 465 ILE B 335 REMARK 465 TYR B 336 REMARK 465 GLU B 373 REMARK 465 TYR B 374 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 761 O HOH B 799 2.09 REMARK 500 OE1 GLN B 370 NE2 GLN B 372 2.11 REMARK 500 O HOH A 675 O HOH A 812 2.14 REMARK 500 O HOH A 718 O HOH A 721 2.15 REMARK 500 O HOH A 641 O HOH A 819 2.16 REMARK 500 OG SER B 111 O HOH B 803 2.16 REMARK 500 O HOH B 763 O HOH B 809 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 784 O HOH A 807 2546 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 348 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 269 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 348 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 261 138.24 -171.18 REMARK 500 PHE A 298 51.40 -107.41 REMARK 500 REMARK 500 REMARK: NULL DBREF 4DTE A 1 374 UNP F1QRB8 F1QRB8_DANRE 19 392 DBREF 4DTE B 1 374 UNP F1QRB8 F1QRB8_DANRE 19 392 SEQRES 1 A 374 ASN LEU ILE GLN ASP LYS GLN THR ASP PHE GLY LEU GLN SEQRES 2 A 374 VAL PHE ALA GLU ALA VAL GLN SER ALA PRO ASP ARG ASN SEQRES 3 A 374 LEU ALA LEU SER PRO TYR GLY ILE ALA SER VAL LEU GLY SEQRES 4 A 374 MET ALA GLN MET GLY ALA TYR GLY ALA THR LEU LYS LEU SEQRES 5 A 374 LEU ALA SER LYS MET GLY TYR SER LEU GLN GLU ARG GLY SEQRES 6 A 374 MET PRO LYS LEU GLN ARG LEU LEU GLN ARG ASP LEU ALA SEQRES 7 A 374 SER GLU ASP GLY VAL GLU VAL ALA SER GLY VAL MET VAL SEQRES 8 A 374 ASP ARG LYS ILE ILE LEU GLU LYS VAL PHE ARG ARG SER SEQRES 9 A 374 LEU SER LYS ALA PHE GLN SER VAL PRO HIS GLN ILE ASP SEQRES 10 A 374 PHE SER GLN PRO GLU MET ALA ARG GLN VAL ILE ASN SER SEQRES 11 A 374 TRP THR SER ASP HIS THR ASP GLY MET ILE SER GLU PHE SEQRES 12 A 374 LEU PRO SER GLY VAL LEU SER GLU LEU THR ARG LEU VAL SEQRES 13 A 374 PHE LEU ASN ALA LEU HIS PHE HIS GLY VAL TRP LYS THR SEQRES 14 A 374 PRO PHE ASP PRO ARG ASN THR ARG GLU GLN LEU PHE HIS SEQRES 15 A 374 THR VAL ASN GLY SER ALA VAL SER VAL PRO MET MET THR SEQRES 16 A 374 THR THR GLN LYS PHE ASN TYR GLY GLU PHE VAL SER LYS SEQRES 17 A 374 ASP GLY VAL ASP TYR ASP VAL ILE GLU MET PRO TYR GLU SEQRES 18 A 374 GLY GLU SER ILE SER MET LEU LEU VAL THR PRO PHE GLU SEQRES 19 A 374 LYS ASP VAL PRO LEU SER ALA LEU ASN LYS GLU LEU SER SEQRES 20 A 374 SER SER ARG ILE HIS GLN TRP ARG GLN GLU MET ARG LYS SEQRES 21 A 374 ILE SER LYS GLN LEU SER ILE PRO ARG PHE SER MET ASP SEQRES 22 A 374 THR GLU ILE ASP LEU LYS SER THR LEU SER ARG MET GLY SEQRES 23 A 374 LEU GLY ASP ILE PHE SER GLN SER ARG ALA ASP PHE SER SEQRES 24 A 374 ARG ILE THR THR GLU GLU PRO LEU CYS VAL SER LYS VAL SEQRES 25 A 374 LEU GLN ARG VAL LYS LEU GLU VAL ASN GLU GLU GLY THR SEQRES 26 A 374 LYS GLY SER SER ALA THR ALA ALA VAL ILE TYR SER ARG SEQRES 27 A 374 MET ALA VAL GLU GLU ILE THR LEU ASP ARG PRO PHE PHE SEQRES 28 A 374 PHE LEU ILE GLN HIS LYS PRO THR GLY ALA LEU LEU PHE SEQRES 29 A 374 SER GLY GLN LEU THR GLN PRO GLN GLU TYR SEQRES 1 B 374 ASN LEU ILE GLN ASP LYS GLN THR ASP PHE GLY LEU GLN SEQRES 2 B 374 VAL PHE ALA GLU ALA VAL GLN SER ALA PRO ASP ARG ASN SEQRES 3 B 374 LEU ALA LEU SER PRO TYR GLY ILE ALA SER VAL LEU GLY SEQRES 4 B 374 MET ALA GLN MET GLY ALA TYR GLY ALA THR LEU LYS LEU SEQRES 5 B 374 LEU ALA SER LYS MET GLY TYR SER LEU GLN GLU ARG GLY SEQRES 6 B 374 MET PRO LYS LEU GLN ARG LEU LEU GLN ARG ASP LEU ALA SEQRES 7 B 374 SER GLU ASP GLY VAL GLU VAL ALA SER GLY VAL MET VAL SEQRES 8 B 374 ASP ARG LYS ILE ILE LEU GLU LYS VAL PHE ARG ARG SER SEQRES 9 B 374 LEU SER LYS ALA PHE GLN SER VAL PRO HIS GLN ILE ASP SEQRES 10 B 374 PHE SER GLN PRO GLU MET ALA ARG GLN VAL ILE ASN SER SEQRES 11 B 374 TRP THR SER ASP HIS THR ASP GLY MET ILE SER GLU PHE SEQRES 12 B 374 LEU PRO SER GLY VAL LEU SER GLU LEU THR ARG LEU VAL SEQRES 13 B 374 PHE LEU ASN ALA LEU HIS PHE HIS GLY VAL TRP LYS THR SEQRES 14 B 374 PRO PHE ASP PRO ARG ASN THR ARG GLU GLN LEU PHE HIS SEQRES 15 B 374 THR VAL ASN GLY SER ALA VAL SER VAL PRO MET MET THR SEQRES 16 B 374 THR THR GLN LYS PHE ASN TYR GLY GLU PHE VAL SER LYS SEQRES 17 B 374 ASP GLY VAL ASP TYR ASP VAL ILE GLU MET PRO TYR GLU SEQRES 18 B 374 GLY GLU SER ILE SER MET LEU LEU VAL THR PRO PHE GLU SEQRES 19 B 374 LYS ASP VAL PRO LEU SER ALA LEU ASN LYS GLU LEU SER SEQRES 20 B 374 SER SER ARG ILE HIS GLN TRP ARG GLN GLU MET ARG LYS SEQRES 21 B 374 ILE SER LYS GLN LEU SER ILE PRO ARG PHE SER MET ASP SEQRES 22 B 374 THR GLU ILE ASP LEU LYS SER THR LEU SER ARG MET GLY SEQRES 23 B 374 LEU GLY ASP ILE PHE SER GLN SER ARG ALA ASP PHE SER SEQRES 24 B 374 ARG ILE THR THR GLU GLU PRO LEU CYS VAL SER LYS VAL SEQRES 25 B 374 LEU GLN ARG VAL LYS LEU GLU VAL ASN GLU GLU GLY THR SEQRES 26 B 374 LYS GLY SER SER ALA THR ALA ALA VAL ILE TYR SER ARG SEQRES 27 B 374 MET ALA VAL GLU GLU ILE THR LEU ASP ARG PRO PHE PHE SEQRES 28 B 374 PHE LEU ILE GLN HIS LYS PRO THR GLY ALA LEU LEU PHE SEQRES 29 B 374 SER GLY GLN LEU THR GLN PRO GLN GLU TYR MODRES 4DTE ASN B 185 ASN GLYCOSYLATION SITE MODRES 4DTE ASN A 185 ASN GLYCOSYLATION SITE HET NAG A 500 14 HET NAG B 500 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 5 HOH *443(H2 O) HELIX 1 1 ASN A 1 ALA A 22 1 22 HELIX 2 2 SER A 30 ALA A 45 1 16 HELIX 3 3 TYR A 46 GLY A 58 1 13 HELIX 4 4 GLY A 65 SER A 79 1 15 HELIX 5 5 GLU A 98 GLN A 110 1 13 HELIX 6 6 GLN A 120 HIS A 135 1 16 HELIX 7 7 ASP A 172 THR A 176 5 5 HELIX 8 8 PRO A 238 LEU A 246 5 9 HELIX 9 9 SER A 247 MET A 258 1 12 HELIX 10 10 LEU A 278 MET A 285 1 8 HELIX 11 11 LEU A 287 SER A 292 5 6 HELIX 12 12 LEU B 2 ALA B 22 1 21 HELIX 13 13 SER B 30 ALA B 45 1 16 HELIX 14 14 TYR B 46 GLY B 58 1 13 HELIX 15 15 GLY B 65 SER B 79 1 15 HELIX 16 16 GLU B 98 GLN B 110 1 13 HELIX 17 17 GLN B 120 THR B 136 1 17 HELIX 18 18 ASP B 172 THR B 176 5 5 HELIX 19 19 PRO B 238 ASN B 243 5 6 HELIX 20 20 SER B 247 MET B 258 1 12 HELIX 21 21 LEU B 278 MET B 285 1 8 HELIX 22 22 LEU B 287 SER B 292 5 6 SHEET 1 A 7 LEU A 27 LEU A 29 0 SHEET 2 A 7 LEU A 362 LEU A 368 -1 O SER A 365 N LEU A 29 SHEET 3 A 7 PHE A 350 HIS A 356 -1 N PHE A 350 O LEU A 368 SHEET 4 A 7 ILE A 225 PRO A 232 -1 N LEU A 228 O LEU A 353 SHEET 5 A 7 ASP A 212 PRO A 219 -1 N MET A 218 O MET A 227 SHEET 6 A 7 ALA A 188 VAL A 206 -1 N PHE A 205 O TYR A 213 SHEET 7 A 7 ARG A 177 HIS A 182 -1 N GLN A 179 O VAL A 191 SHEET 1 B 8 LEU A 27 LEU A 29 0 SHEET 2 B 8 LEU A 362 LEU A 368 -1 O SER A 365 N LEU A 29 SHEET 3 B 8 PHE A 350 HIS A 356 -1 N PHE A 350 O LEU A 368 SHEET 4 B 8 ILE A 225 PRO A 232 -1 N LEU A 228 O LEU A 353 SHEET 5 B 8 ASP A 212 PRO A 219 -1 N MET A 218 O MET A 227 SHEET 6 B 8 ALA A 188 VAL A 206 -1 N PHE A 205 O TYR A 213 SHEET 7 B 8 ARG A 259 PRO A 268 -1 O ILE A 261 N PHE A 200 SHEET 8 B 8 GLU A 343 THR A 345 1 O ILE A 344 N GLN A 264 SHEET 1 C 5 HIS A 114 ILE A 116 0 SHEET 2 C 5 VAL A 83 ASP A 92 1 N VAL A 89 O HIS A 114 SHEET 3 C 5 LEU A 155 PHE A 163 -1 O HIS A 162 N GLU A 84 SHEET 4 C 5 LYS A 311 VAL A 320 1 O LEU A 313 N PHE A 157 SHEET 5 C 5 PHE A 270 ASP A 277 -1 N PHE A 270 O VAL A 320 SHEET 1 D 7 LEU B 27 LEU B 29 0 SHEET 2 D 7 LEU B 362 LEU B 368 -1 O SER B 365 N LEU B 29 SHEET 3 D 7 PHE B 350 HIS B 356 -1 N PHE B 352 O GLY B 366 SHEET 4 D 7 ILE B 225 PRO B 232 -1 N LEU B 228 O LEU B 353 SHEET 5 D 7 ASP B 212 PRO B 219 -1 N MET B 218 O MET B 227 SHEET 6 D 7 ALA B 188 VAL B 206 -1 N PHE B 205 O TYR B 213 SHEET 7 D 7 ARG B 177 HIS B 182 -1 N ARG B 177 O MET B 193 SHEET 1 E 8 LEU B 27 LEU B 29 0 SHEET 2 E 8 LEU B 362 LEU B 368 -1 O SER B 365 N LEU B 29 SHEET 3 E 8 PHE B 350 HIS B 356 -1 N PHE B 352 O GLY B 366 SHEET 4 E 8 ILE B 225 PRO B 232 -1 N LEU B 228 O LEU B 353 SHEET 5 E 8 ASP B 212 PRO B 219 -1 N MET B 218 O MET B 227 SHEET 6 E 8 ALA B 188 VAL B 206 -1 N PHE B 205 O TYR B 213 SHEET 7 E 8 ARG B 259 PRO B 268 -1 O ARG B 259 N TYR B 202 SHEET 8 E 8 GLU B 342 THR B 345 1 O GLU B 342 N GLN B 264 SHEET 1 F 5 HIS B 114 ILE B 116 0 SHEET 2 F 5 VAL B 83 ASP B 92 1 N VAL B 89 O HIS B 114 SHEET 3 F 5 LEU B 155 PHE B 163 -1 O VAL B 156 N MET B 90 SHEET 4 F 5 LYS B 311 VAL B 320 1 O LEU B 313 N PHE B 157 SHEET 5 F 5 PHE B 270 ASP B 277 -1 N THR B 274 O VAL B 316 LINK ND2 ASN A 185 C1 NAG A 500 1555 1555 1.47 LINK ND2 ASN B 185 C1 NAG B 500 1555 1555 1.45 CISPEP 1 ASN B 185 GLY B 186 0 -4.41 CRYST1 65.160 73.770 91.750 90.00 102.73 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015347 0.000000 0.003467 0.00000 SCALE2 0.000000 0.013556 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011174 0.00000